Vinorelbine in elderly patients with inoperable nonsmall cell lung carcinoma: a phase II study (Q73931415)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870049%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Vinorelbine in elderly patients with inoperable nonsmall cell lung carcinoma: a phase II study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870049%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

G Buccheri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870049%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D Ferrigno

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870049%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870049%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870049%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870049%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870049%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

2677-2685

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870049%20AND%20SRC:MED&resulttype=core&format=json

Chemotherapy and survival of patients with non-small cell lung cancer. A contrary view

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Should non-small cell carcinoma of the lung be treated with chemotherapy? Con: therapeutic empiricism--the case against chemotherapy in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Chemotherapy in non-small cell lung cancer: time to re-examine our attitudes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Chemotherapy and survival in non-small cell lung cancer. The old vexata questio

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Chemotherapy and survival in non-small cell lung cancer. Three years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Local research ethics committees

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Vinorelbine treatment of advanced non-small cell lung cancer with special emphasis on elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Phase I-II study of vinorelbine (Navelbine) plus cisplatin in advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Revisions in the International System for Staging Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

A therapy impact questionnaire for quality-of-life assessment in advanced cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Carboplatin, etoposide, and accelerated hyperfractionated radiotherapy for elderly patients with limited small cell lung carcinoma: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Full chemotherapy in elderly patients with small cell bronchial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Clinical benefit from palliative chemotherapy in non-small-cell lung cancer extends to the elderly and those with poor prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Efficacy of platinum-based regimens in non-small cell lung cancer. A negative report from the Cuneo Lung Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

Platinum-based chemotherapy for inoperable non-small cell lung cancer: a real therapeutic progress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%3C2677%3A%3AAID-CNCR5%3E3.0.CO%3B2-B

10.1002/1097-0142(20000615)88:12<2677::AID-CNCR5>3.0.CO;2-B

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10870049%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference